hydroxyproline has been researched along with risedronic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballah, A; Hosking, DJ; Mundy, GR; Reasner, CA; Stone, MD | 1 |
| Bekker, PJ; Clemens, TL; Eusebio, RA; Singer, FR | 1 |
2 other study(ies) available for hydroxyproline and risedronic acid
| Article | Year |
|---|---|
Acute changes in calcium homeostasis during treatment of primary hyperparathyroidism with risedronate.
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Analysis of Variance; Bone Resorption; Calcium; Etidronic Acid; Female; Homeostasis; Humans; Hydroxyproline; Hyperparathyroidism; Kidney Tubules; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Postmenopause; Risedronic Acid | 1993 |
Risedronate, a highly effective oral agent in the treatment of patients with severe Paget's disease.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Calcitriol; Calcium; Calcium Channel Blockers; Creatinine; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Parathyroid Hormone; Phosphorus; Risedronic Acid | 1998 |